PLRX · TickerCove

PLRXPliant Therapeutics, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $1.07 · now $1.07 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, PLRX has typically landed between $0.81 and $1.38 — a range of −24.7% to +29.0% from the issuance price $1.07.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,557 overlapping 1 month windows · 2020-06-03 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($1.07) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$1.07 · 5% of range

$1.03 low$1.87 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−4.3%

typical move · IQR 18.8%

−24.7%worst (p90)+29.0%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where PLRX has typically landed a month from the 2026-09-16 close of $1.07 — the range is history, not a prediction.

now $1.07 (+0.0%)
typical $1.02 (-4.3%)
middle 50% $0.9226–$1.12
90% range $0.8056–$1.38

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,557 windows spanning 2020-06-03 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2025-02-05	−88.6%	−89.2%	+0.0%
2025-01-30	−87.3%	−87.3%	+17.7%
2025-01-29	−87.2%	−87.2%	+16.9%
3 best
2022-06-13	+206.1%	+0.0%	+210.2%
2022-06-10	+195.0%	−4.9%	+195.0%
2022-06-16	+189.6%	+0.0%	+201.0%

1,557 overlapping windows · 2020-06-03 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

33%

+9.4%

n=6

Feb

33%

−11.7%

n=6

Mar

17%

−14.9%

n=6

Apr

33%

−5.2%

n=6

May

33%

−7.8%

n=6

Jun

17%

−2.0%

n=6

Jul

43%

+15.2%

n=7

Aug

57%

+2.1%

n=7

Sep

29%

−4.9%

n=7

Oct

50%

+5.4%

n=6

Nov

17%

−3.5%

n=6

Dec

33%

−2.6%

n=6

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-01-20	Coulie Bernard	director	Sale	89,375 @ $1.28	$114K	−15.0% of holding	+0.5%	−25.0%	505,601	Form 4 · filed 2 days after the trade
2026-01-20	Cummings Keith Lamont	officer	Sale	24,002 @ $1.28	$31K	−7.5% of holding	+0.5%	−25.0%	297,214	Form 4 · filed 2 days after the trade
2026-01-20	Cheung Lily	officer	Sale	7,534 @ $1.28	$10K	−14.4% of holding	+0.5%	−25.0%	44,847	Form 4 · filed 2 days after the trade
2026-01-20	Kuo Minnie	officer	Sale	6,917 @ $1.28	$9K	−15.5% of holding	+0.5%	−25.0%	37,806	Form 4 · filed 2 days after the trade
2025-01-22	Ouimette Mike	officer	Sale	10,230 @ $10.99	$112K	−12.7% of holding	−70.7%	−91.3%	70,544	Form 4 · filed same day
2025-01-17	Coulie Bernard	director	Sale	52,419 @ $11.20	$587K	−10.9% of holding	−75.3%	−92.7%	430,517	Form 4 · filed 5 days after the trade
2025-01-17	Cummings Keith Lamont	officer	Sale	20,148 @ $11.20	$226K	−7.1% of holding	−75.3%	−92.7%	262,608	Form 4 · filed 5 days after the trade
2025-01-17	Lefebvre Eric	officer	Sale	18,478 @ $11.20	$207K	−8.7% of holding	−75.3%	−92.7%	194,574	Form 4 · filed 5 days after the trade
2025-01-17	Hull Hans	officer	Sale	15,936 @ $11.20	$179K	−7.0% of holding	−75.3%	−92.7%	211,558	Form 4 · filed 5 days after the trade
2025-01-17	Ouimette Mike	officer	Sale	13,270 @ $11.20	$149K	−14.1% of holding	−75.3%	−92.7%	80,774	Form 4 · filed 5 days after the trade
2025-01-17	Cheung Lily	officer	Sale	3,740 @ $11.20	$42K	−13.2% of holding	−75.3%	−92.7%	24,550	Form 4 · filed 5 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

71 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-07-09	Iannone Robert	director	Award / grant	60,000	60,000	Form 4
2026-07-09	Borellini Flavia	director	Award / grant	60,000	60,000	Form 4
2026-06-11	Curnutte John T	director	Award / grant	70,000	70,000	Form 4
2026-06-11	Huh Hoyoung	director	Award / grant	70,000	70,000	Form 4
2026-06-11	CROWELL GAYLE A	director	Award / grant	70,000	70,000	Form 4
2026-06-11	Krognes Steve E.	director	Award / grant	70,000	70,000	Form 4
2026-06-11	MCCOURT Thomas A	director	Award / grant	70,000	70,000	Form 4
2026-06-11	Cline Darren S	director	Award / grant	70,000	70,000	Form 4
2026-04-17	Coulie Bernard	director	Award / grant	440,000	440,000	Form 4
2026-04-17	Coulie Bernard	director	Disposition	206,300	0	Form 4
2026-04-17	Coulie Bernard	director	Award / grant	206,300	206,300	Form 4
2026-04-17	Coulie Bernard	director	Disposition	256,300	0	Form 4
2026-04-17	Coulie Bernard	director	Award / grant	256,300	256,300	Form 4
2026-04-17	Coulie Bernard	director	Award / grant	325,000	325,000	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	110,500	110,500	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	76,047	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	76,047	76,047	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	18,198	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	18,198	18,198	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	74,250	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	74,250	74,250	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	124,000	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	124,000	124,000	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	76,200	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	76,200	76,200	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	110,500	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Disposition	113,300	0	Form 4
2026-04-17	Cummings Keith Lamont	officer	Award / grant	113,300	113,300	Form 4
2026-04-17	Kuo Minnie	officer	Award / grant	55,200	55,200	Form 4
2026-04-17	Cheung Lily	officer	Disposition	123,000	0	Form 4
2026-04-17	Cheung Lily	officer	Award / grant	123,000	123,000	Form 4
2026-04-17	Cheung Lily	officer	Disposition	52,000	0	Form 4
2026-04-17	Cheung Lily	officer	Award / grant	52,000	52,000	Form 4
2026-04-17	Cheung Lily	officer	Disposition	51,750	0	Form 4
2026-04-17	Cheung Lily	officer	Award / grant	51,750	51,750	Form 4
2026-04-17	Kuo Minnie	officer	Disposition	150,000	0	Form 4
2026-04-17	Kuo Minnie	officer	Award / grant	150,000	150,000	Form 4
2026-04-17	Kuo Minnie	officer	Disposition	40,000	0	Form 4
2026-04-17	Kuo Minnie	officer	Award / grant	40,000	40,000	Form 4
2026-04-17	Kuo Minnie	officer	Disposition	55,200	0	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i